Archiving and Documenting Data from the NICHD Neonatal Research Network
归档和记录来自 NICHD 新生儿研究网络的数据
基本信息
- 批准号:9803847
- 负责人:
- 金额:$ 8.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-09 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:Access to InformationAdverse eventAffectArchivesBenchmarkingBirthBirth WeightBronchopulmonary DysplasiaCaringCessation of lifeChild HealthClinicalClinical TrialsCommunitiesContinuous Positive Airway PressureDataData Coordinating CenterData ElementData SetDocumentationEnsureFundingFutureGestational AgeGoalsHourHuman DevelopmentInfantInfrastructureInstitutional Review BoardsInternationalInterventionInvestigationKnowledgeLow Birth Weight InfantLung diseasesMeasurableMedicineMeta-AnalysisMonitorMorbidity - disease rateMulticenter Neonatal Research NetworkNational Institute of Child Health and Human DevelopmentNeonatalNeonatal Intensive Care UnitsNewborn InfantOutcomeOxygenParticipantPhysiologic pulsePregnancyPremature InfantPreventive therapyPrincipal InvestigatorPublishingPulse OximetryReportingResearchResearch DesignResearch PersonnelResourcesRespiratory FailureSafetySpecimenSubgroupSurvival RateTestingTrainingTreatment EfficacyTreatment ProtocolsUnited States National Institutes of Healthclinical research sitedata warehouseevidence baseexperienceimprovedinhaled nitric oxideneonatal careneonateprematurepressurepreventrandomized trialrepositoryrespiratoryresponsesurfactanttreatment strategytrial comparing
项目摘要
Project Summary
The Neonatal Research Network (NRN) was established by the Eunice Kennedy Shriver National Institute
of Child Health and Human Development (NICHD) in 1993 to facilitate the advancement of neonatal care by
establishing a network of academic centers that, by rigorous investigation of the safety and efficacy of
treatment strategies for newborn infants, can meaningfully enhance the evidence base for neonatal medicine.
The Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure (Preemie iNO) Trial, the
Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia (Benchmarking Trial), and the Surfactant
Positive Airway Pressure and Pulse Oximetry Trial (SUPPORT) are three studies involving respiratory
management strategies and outcomes for extremely premature/low birthweight neonates conducted by the
NRN before the NICHD Data and Specimen Hub (N-DASH) became available (2000-2009). The Preemie iNO
trial tested whether inhaled nitric oxide reduces death or bronchopulmonary dysplasia (BPD) in low birth weight
(401-1500 g) infants less than 34 weeks gestational age with severe lung disease. The Benchmarking trial
tested whether Neonatal Intensive Care Unit teams trained in benchmarking—comparing care practices
between different NICUs to see which practices prevent BPD—and quality improvement would change
practices and improve rates of survival without BPD in inborn neonates with birth weights <1250 g. SUPPORT
compared continuous positive airway pressure initiated at birth with early administration of surfactant for infants
born at 24 to 27 weeks gestation to determine the effect on BPD and survival of premature infants. The results
of all these studies have been published, but comprehensive datasets and documentation are not available in
any publicly accessible data repository. Meanwhile, these data remain highly valuable to researchers,
particularly given that despite measurable improvements in neonatal care over the past 30 years, BPD rates
have not improved for extremely premature babies and few efficacious preventive therapies exist. However,
because these studies were completed prior to the existence of N-DASH, they are not available in a public
repository that would make them proactively available to researchers to spark new investigations. Therefore,
RTI International proposes to use our institutional knowledge of the NRN and our DCC infrastructure to
achieve the following specific aims in response to PAR-16-149 Archiving and Documenting Child Health and
Human Development Data Sets (R03): (1) create public use datasets and documentation for the Preemie iNO,
Benchmarking, and SUPPORT trials; (2) harmonize the data to facilitate analyses that make use of data from
multiple studies; and (3) share the public use datasets and documentation through N-DASH.
项目摘要
新生儿研究网络(NRN)是由尤尼斯肯尼迪施莱佛国家研究所建立的
1993年,儿童健康与人类发展委员会(NICHD)成立,通过以下措施促进新生儿护理的发展
建立一个学术中心网络,通过严格调查的安全性和有效性,
新生儿的治疗策略,可以有意义地加强新生儿医学的证据基础。
吸入一氧化氮治疗严重呼吸衰竭早产儿(早产儿iNO)试验,
减少支气管肺发育不良的基准计划(基准试验)和表面活性剂
气道正压通气和脉搏血氧测定试验(SUPPORT)是三项涉及呼吸系统的研究,
极早产/低出生体重新生儿的管理策略和结果
NRN在NICHD数据和标本中心(N-DASH)可用之前(2000-2009年)。早产儿iNO
一项试验测试了吸入一氧化氮是否会降低低出生体重儿的死亡或支气管肺发育不良(BPD)
(401-1500 g)胎龄小于34周的患有严重肺部疾病的婴儿。基准测试
测试新生儿重症监护室团队是否接受过基准比较护理实践的培训
在不同的NICU之间,看看哪些实践可以防止BPD-质量改进会发生变化
提高出生体重<1250 g的新生儿无BPD的存活率。支持
比较出生时开始的持续气道正压通气与婴儿早期给予表面活性物质
在妊娠24至27周出生,以确定对BPD和早产儿存活率的影响。结果
所有这些研究都已发表,但全面的数据集和文件在
任何可公开访问的数据存储库。与此同时,这些数据对研究人员来说仍然非常有价值,
特别是考虑到尽管在过去30年中新生儿护理有了可衡量的改善,
对于极早产儿没有改善,并且几乎没有有效的预防性治疗。然而,在这方面,
由于这些研究是在N-DASH存在之前完成的,因此无法公开获得
这将使他们主动提供给研究人员,以激发新的调查。因此,我们认为,
RTI国际建议利用我们对NRN和DCC基础设施的机构知识,
实现以下具体目标,以响应PAR-16-149《儿童健康和记录》,
人类发育数据集(R 03):(1)为早产儿iNO创建公共使用数据集和文档,
基准测试和支持试验;(2)协调数据,以促进利用来自
多项研究;(3)通过N-DASH共享公共使用数据集和文档。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Abhik Das其他文献
Abhik Das的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Abhik Das', 18)}}的其他基金
Neonatal Research Network Data Coordinating Center (DCC) 2023-2028
新生儿研究网络数据协调中心 (DCC) 2023-2028
- 批准号:
10879205 - 财政年份:2023
- 资助金额:
$ 8.94万 - 项目类别:
Data Coordinating Center (DCC) for the Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial (NOWS PhaCET)
数据协调中心 (DCC) 新生儿阿片类药物戒断综合征药物治疗比较有效性试验 (NOWS PhaCET)
- 批准号:
10491217 - 财政年份:2021
- 资助金额:
$ 8.94万 - 项目类别:
Data Coordinating Center (DCC) for the Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial (NOWS PhaCET)
数据协调中心 (DCC) 新生儿阿片类药物戒断综合征药物治疗比较有效性试验 (NOWS PhaCET)
- 批准号:
10378283 - 财政年份:2021
- 资助金额:
$ 8.94万 - 项目类别:
Data Coordinating Center (DCC) for the Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial (NOWS PhaCET)
数据协调中心 (DCC) 新生儿阿片类药物戒断综合征药物治疗比较有效性试验 (NOWS PhaCET)
- 批准号:
10678679 - 财政年份:2021
- 资助金额:
$ 8.94万 - 项目类别:
Data Coordinating Center for the NICHD Neonatal Research Network (U24)
NICHD 新生儿研究网络数据协调中心 (U24)
- 批准号:
10375431 - 财政年份:2018
- 资助金额:
$ 8.94万 - 项目类别:
Data Coordinating Center for the NICHD Neonatal Research Network (U24)
NICHD 新生儿研究网络数据协调中心 (U24)
- 批准号:
9983354 - 财政年份:2018
- 资助金额:
$ 8.94万 - 项目类别:
Neonatal Research Network Data Coordinating Center (DCC) 2023-2028
新生儿研究网络数据协调中心 (DCC) 2023-2028
- 批准号:
10833754 - 财政年份:2018
- 资助金额:
$ 8.94万 - 项目类别:
Transfusion of Prematurity Early School Age Follow-up (TOP 5) DCC
早产儿输血早期学龄随访(TOP 5)DCC
- 批准号:
10247622 - 财政年份:2018
- 资助金额:
$ 8.94万 - 项目类别:
Transfusion of Prematurity Early School Age Follow-up (TOP 5) DCC
早产儿输血早期学龄随访(TOP 5)DCC
- 批准号:
10021687 - 财政年份:2018
- 资助金额:
$ 8.94万 - 项目类别:
Data Coordinating Center for the NICHD Neonatal Research Network (U24)
NICHD 新生儿研究网络数据协调中心 (U24)
- 批准号:
9898399 - 财政年份:2018
- 资助金额:
$ 8.94万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 8.94万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 8.94万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 8.94万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 8.94万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 8.94万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 8.94万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 8.94万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 8.94万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 8.94万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 8.94万 - 项目类别: